← Eichor
Study identifier: NCT07298954 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sequential Combined Versus Single-Strategy Adrenal Venous Sampling for Primary Aldosteronism(SCOPE)

Condition: Primary Aldosteronism  ·  Sponsor: Shumin Yang

PhaseNA
Planned participants456
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This study is a prospective, multicenter, randomized clinical trial aimed to compare the impact of three AVS diagnostic strategies on the clinical outcomes of patients with primary aldosteronism. The strategies include sequential combined AVS (non-ACTH-stimulated followed by ACTH-stimulated AVS), non- ACTH-stimulated AVS alone, and ACTH-stimulated AVS alone. The findings of this study will provide critical evidence for the clinical practice standards of AVS.

This description comes directly from the study's public registry record.

Talk to the study team

Shumin Yang  ·  +86 023-89011552  ·  ysm@hospital.cqmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affilated Hospital of Chongqing Medical UniversityChongqing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07298954